Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Quick Stats
Apr 28, 202664.3
AI Score
BUY0.71
Volume Ratio
May 07, 2026
Next Earnings
20
+ve Days (30d)
10
-ve Days (30d)
ZYME Stock Summary
Last updated Apr 28, 2026
ZYME is currently trading at $27.94, positioned above its 200-day moving average of $20.83, indicating a long-term uptrend. The stock has a 52-week range of $10.86 to $29.75.
Technical Analysis: The 50-day moving average stands at $25.15, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.147, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.177, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ZYME at 64.3/100 with a BUY recommendation.
ZYME (Zymeworks Inc.) Indicators
Last updated Apr 28, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.147 |
| CMF (20) | 0.177 |
| ROC (10) | 3.558 |
| ADX (14) | 31.758 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.953 |
| AROONOSC (14) | 71.429 |
| WILLAMS %R (14) | -46.173 |
| MFI (14) | 63.617 |
ZYME Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ZYME Price vs Max Options Open Interest
ZYME Max Change In Options Open Interest
ZYME Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Daily Out of Money Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Daily In the Money Options - Sort by Max open Interest (near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ZYME Most Active Options by Volume(near term)
29th April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Zymeworks Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
ZYME Moving Averages Analysis
Zymeworks Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 28, 2026
Zymeworks Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 28, 2026
ZYME (Zymeworks Inc.) Simple Moving Averages
Moving Averages are last updated Apr 28, 2026
| Days | MA |
|---|---|
| 10 | 27.94 |
| 20 | 27.08 |
| 30 | 26.04 |
| 50 | 25.15 |
| 100 | 24.85 |
| 200 | 20.83 |
ZYME Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 2.1 billion |
| Earnings/Share ($) | -1.08 |
| Net Proft Margin (%) | -0.7656 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 1.2265 |
| EPS Estimate Next Year ($) | 0.7873 |
| WallStreet Target Price ($) | 40.0769 |
| Most Recent Quarter |